Clinical Trial Update: Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating risedronate to prevent skeletal-related events in patients with metastatic prostate cancer starting hormonal therapy was terminated, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: Christopher Sweeney, MBBS | Conditions: Metastatic Prostate Cancer | Phase 3 | Status: TERMINATED | Results posted: 2016-05-26